Le Lézard
Classified in: Health
Subject: PDT

Crown Aesthetics Announces Addition Of ProGen PRPtm Advantage To ProGen PRP Portfolio


DALLAS, Jan. 24, 2020 /PRNewswire/ -- Leader in advanced aesthetic solutions, Crown Aesthetics, a division of Crown Laboratories, Inc., is proud to announce the launch of ProGen PRPtm Advantage, an easy to use, single spin system that features 15ml and 30ml tubes, yielding 7-15ml of 2x concentration PRP. With the launch of ProGen PRPtm Advantage, physicians will now be able to deliver Platelet Rich Plasma procedures more efficiently and conveniently.

"Crown Aesthetics' passion and relentless drive to bring technological advancements to the aesthetic market is what sets us apart from competitors. Empowering providers with an efficient, and affordable Platelet Rich Plasma system for their patients offers unmatched ROI for physicians across the industry. Our top-of-the-line technology continues to deliver on our core values of safety and efficacy for our customers," says Joe Proctor, Founder and President of Crown Aesthetics.

For more information please call 888.372.3982 or contact your local sales representative.

About Crown Laboratories, Inc.
Crown Laboratories, Inc., a privately held, fully integrated global skin care company is committed to developing and providing a diverse portfolio of aesthetic, beauty, and therapeutic skin care products that improve the quality of life for its customers. An innovative company focused on skin science for life, Crown's unyielding pursuit of delivering therapeutic excellence and enhanced patient outcomes is why it is poised to become a leader in Dermatology and Aesthetics. Crown has been listed on the Inc. 5000 Fastest Growing Privately Held Companies List for six consecutive years and has expanded its distribution to over 25 countries. For more information about Crown or its products, visit www.crownlaboratories.com.

About Crown Aesthetics
Crown Aesthetics, the premier medical aesthetics company, is dedicated to helping leading aesthetic practices around the world grow their businesses. We do that by delivering dramatic results in rejuvenation and restoration. Our non-invasive innovations ? SkinPen®, the first FDA-cleared microneedling device; the post-microneedling protocol SKINFUSE®; the light-activated cream Allumera®; and the platelet-rich plasma systems ProGentm PRP Advantage and Versatm? act as "gateway" products that draw new consumers to practices. Based in Dallas, Texas, Crown Aesthetics sets industry standards for efficacy, safety, and innovation. As a result, our customers consistently deliver the best aesthetic care in the business. For more information, please visit www.crownaesthetics.com.

SOURCE Crown Laboratories, Inc.


These press releases may also interest you

18 fév 2020
Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28® has launched innovative products and instrumentation that help streamline...

18 fév 2020
Biotech Institute, LLC, the global leader in hemp and cannabis plant breeding, science, and innovation, and Booshoot, LLC ("Booshoot") announced today that they have finalized a groundbreaking technology licensing agreement that will set a new...

18 fév 2020
UBM BN Co., Ltd., the fair manager of SECON 2020 originally scheduled for 18 - 20 March 2020 has made the decision to reschedule the event to 6 - 8 July at KINTEX, Korea.   The decision is taken after careful consideration and close consultations...

18 fév 2020
Nanalysis Scientific Corp. ("Nanalysis", TSXV:NSCI) is pleased to announce that it won the award for 'Best New Analytical Product' at the recent Nanotech Exhibition and Conference in Tokyo, Japan. Nanalysis was the only small-cap, non-Japanese...

18 fév 2020
Vanda Pharmaceuticals Inc. (Vanda) today announced it will release results for the fourth quarter and full year 2019 on Tuesday, February 25, 2020, after the market closes.   Vanda will host a conference call at 4:30 PM ET on Tuesday, February 25,...

18 fév 2020
Gilead Sciences, Inc. today announced that Johanna Mercier, Chief Commercial Officer, and Merdad Parsey, MD, PhD, Chief Medical Officer, will participate in a fireside chat at the Cowen and Company 40th Annual Health Care Conference in Boston on...



News published on 24 january 2020 at 08:05 and distributed by: